Day One Biopharmaceuticals (DAWN) Other Non Operating Income (2023 - 2025)
Historic Other Non Operating Income for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Q3 2025 value amounting to -$34000.0.
- Day One Biopharmaceuticals' Other Non Operating Income fell 10284.04% to -$34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$36000.0, marking a year-over-year decrease of 10310.61%. This contributed to the annual value of $1.2 million for FY2024, which is 314250.0% up from last year.
- Latest data reveals that Day One Biopharmaceuticals reported Other Non Operating Income of -$34000.0 as of Q3 2025, which was down 10284.04% from -$19000.0 recorded in Q2 2025.
- In the past 5 years, Day One Biopharmaceuticals' Other Non Operating Income ranged from a high of $1.2 million in Q3 2024 and a low of -$34000.0 during Q3 2025
- For the 3-year period, Day One Biopharmaceuticals' Other Non Operating Income averaged around $110500.0, with its median value being -$12500.0 (2023).
- Per our database at Business Quant, Day One Biopharmaceuticals' Other Non Operating Income surged by 4000000.0% in 2024 and then plummeted by 13000.0% in 2025.
- Quarter analysis of 3 years shows Day One Biopharmaceuticals' Other Non Operating Income stood at -$18000.0 in 2023, then surged by 322.22% to $40000.0 in 2024, then plummeted by 185.0% to -$34000.0 in 2025.
- Its Other Non Operating Income was -$34000.0 in Q3 2025, compared to -$19000.0 in Q2 2025 and -$23000.0 in Q1 2025.